Power and sample size estimation for the Wilcoxon rank sum test with application to comparisons of C statistics from alternative prediction models.

PubWeight™: 1.49‹?› | Rank: Top 4%

🔗 View Article (PMID 18510654)

Published in Biometrics on May 28, 2008

Authors

B Rosner1, R J Glynn

Author Affiliations

1: Channing Laboratory, Harvard Medical School, Boston, Massachusetts 02115, USA. rosner@stat.harvard.edu

Articles citing this

Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci (2008) 2.91

Cardiovascular risk prediction in diabetic men and women using hemoglobin A1c vs diabetes as a high-risk equivalent. Arch Intern Med (2011) 2.43

Performance of reclassification statistics in comparing risk prediction models. Biom J (2011) 1.63

Risk factors for epithelial ovarian cancer by histologic subtype. Am J Epidemiol (2009) 1.62

Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. Ophthalmology (2011) 1.61

Risk prediction models with incomplete data with application to prediction of estrogen receptor-positive breast cancer: prospective data from the Nurses' Health Study. Breast Cancer Res (2008) 1.12

Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion. Cancer (2010) 0.99

Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration. Hum Genomics (2011) 0.95

Three new genetic loci (R1210C in CFH, variants in COL8A1 and RAD51B) are independently related to progression to advanced macular degeneration. PLoS One (2014) 0.94

Risk Prediction for Progression of Macular Degeneration: 10 Common and Rare Genetic Variants, Demographic, Environmental, and Macular Covariates. Invest Ophthalmol Vis Sci (2015) 0.94

Lipoprotein subclass abnormalities and incident hypertension in initially healthy women. Clin Chem (2011) 0.92

The benefits of using genetic information to design prevention trials. Am J Hum Genet (2013) 0.91

Validation of Rosner-Colditz breast cancer incidence model using an independent data set, the California Teachers Study. Breast Cancer Res Treat (2013) 0.90

"Doctor" or "darling"? Decoding the communication partner from ECoG of the anterior temporal lobe during non-experimental, real-life social interaction. Front Hum Neurosci (2012) 0.90

Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer. J Clin Oncol (2014) 0.88

Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy. Int J Cancer (2015) 0.81

Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and Older. J Natl Cancer Inst (2015) 0.79

Development of a Risk Prediction Model to Individualize Risk Factors for Surgical Site Infection After Mastectomy. Ann Surg Oncol (2016) 0.78

Power and sample size estimation for the clustered wilcoxon test. Biometrics (2010) 0.77

Power and sample size calculations for the Wilcoxon-Mann-Whitney test in the presence of death-censored observations. Stat Med (2014) 0.76

Assessing discrimination of risk prediction rules in a clustered data setting. Lifetime Data Anal (2012) 0.75

Validation of a risk prediction tool for coronary heart disease in middle-aged women. BMC Womens Health (2015) 0.75

A Comprehensive Model of Colorectal Cancer by Risk Factor Status and Subsite Using Data From the Nurses' Health Study. Am J Epidemiol (2017) 0.75

Breast cancer risk prediction: an update to the Rosner-Colditz breast cancer incidence model. Breast Cancer Res Treat (2017) 0.75

Articles by these authors

(truncated to the top 100)

A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol (1994) 30.72

Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol (2001) 7.04

Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA (1994) 5.38

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation (1998) 4.80

Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Clin Pharmacol Ther (2008) 4.54

Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA (1994) 3.86

A prospective study of cigarette smoking and risk of cataract in men. JAMA (1992) 3.72

The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. A case-control study. Microbial Keratitis Study Group. N Engl J Med (1989) 3.63

Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med (1987) 3.34

Light-to-moderate alcohol consumption and risk of stroke among U.S. male physicians. N Engl J Med (1999) 3.21

The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. N Engl J Med (1989) 3.11

Epidemiologic aspects of uveal melanoma. Surv Ophthalmol (1988) 2.85

Increased pulse pressure and risk of heart failure in the elderly. JAMA (1999) 2.74

Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med (1994) 2.62

Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst (1993) 2.52

HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA (1995) 2.46

Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health (1996) 2.33

A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA (1996) 2.27

Survival of spiral ganglion cells in profound sensorineural hearing loss: implications for cochlear implantation. Ann Otol Rhinol Laryngol (1989) 2.24

Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men. Hypertension (2000) 2.23

The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens (1997) 2.21

Relations of body fat distribution and height with cataract in men. Am J Clin Nutr (2000) 2.20

Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested. JAMA (1995) 2.15

Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med (2001) 2.13

The renal effects of nonsteroidal anti-inflammatory drugs in older people: findings from the Established Populations for Epidemiologic Studies of the Elderly. J Am Geriatr Soc (1999) 2.12

A systematic overview of the incidence of posterior capsule opacification. Ophthalmology (1998) 1.98

The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol (1985) 1.95

Treatment for glaucoma: adherence by the elderly. Am J Public Health (1993) 1.90

Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation (2001) 1.86

Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med (1997) 1.85

Definition of race and ethnicity in older people in Medicare and Medicaid. J Am Geriatr Soc (1999) 1.82

Evaluation of prior primary malignancy as a determinant of uveal melanoma. A case-control study. Ophthalmology (1989) 1.82

Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry (2001) 1.80

Survival of patients with metastases from uveal melanoma. Ophthalmology (1991) 1.80

Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly. J Gerontol (1992) 1.78

Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy. J Am Coll Cardiol (2001) 1.77

Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study. Ann Intern Med (1998) 1.71

Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD) Am Heart J (1999) 1.70

Zolpidem use and hip fractures in older people. J Am Geriatr Soc (2001) 1.68

Association of visual impairment with mobility and physical function. J Am Geriatr Soc (1994) 1.68

Musculoskeletal disease research: should we analyze the joint or the person? J Rheumatol (1996) 1.63

Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol (1990) 1.62

D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. J Thromb Haemost (2006) 1.62

Trends in medication choices for hypertension in the elderly. The decline of the thiazides. Hypertension (1995) 1.60

Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development. Clin Pharmacol Ther (2011) 1.59

Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch Intern Med (1997) 1.58

Analytic strategies for recurrent events in epidemiologic studies: background and application to hospitalization risk in the elderly. J Clin Epidemiol (2000) 1.53

Predictors of uncontrolled hypertension in ambulatory patients. Hypertension (2001) 1.49

Six-year effect of depressive symptoms on the course of physical disability in community-living older adults. Arch Intern Med (2000) 1.49

Evaluation of an iris color classification system. The Eye Disorders Case-Control Study Group. Invest Ophthalmol Vis Sci (1990) 1.48

Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? Arch Intern Med (2000) 1.47

Type of alcoholic beverage and risk of myocardial infarction. Am J Cardiol (1999) 1.46

Determinants of delayed nephrologist referral in patients with chronic kidney disease. Am J Kidney Dis (2001) 1.45

Cataract extraction after proton beam irradiation for malignant melanoma of the eye. Arch Ophthalmol (1992) 1.45

Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med (1993) 1.44

Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch Intern Med (1994) 1.41

Late referral and modality choice in end-stage renal disease. Kidney Int (2001) 1.40

Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study. Ann Intern Med (2001) 1.39

Functional blindness and visual impairment in older adults from three communities. Ophthalmology (1992) 1.36

Prospective cohort study of antioxidant vitamin supplement use and the risk of age-related maculopathy. Am J Epidemiol (1999) 1.35

Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort. J Am Coll Cardiol (2000) 1.34

Factors influencing predilection and outcome in bacterial keratitis. Cornea (1989) 1.33

Uveal melanomas near the optic disc or fovea. Visual results after proton beam irradiation. Ophthalmology (1987) 1.26

Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA (1994) 1.24

White blood cell count as a predictor of mortality: results over 18 years from the Normative Aging Study. J Clin Epidemiol (1990) 1.22

Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy. J Thromb Haemost (2009) 1.22

Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol (2001) 1.22

Aging and generational effects on drinking behaviors in men: results from the normative aging study. Am J Public Health (1985) 1.21

Thiazide diuretics and the initiation of anti-gout therapy. J Clin Epidemiol (1997) 1.20

Active safety monitoring of newly marketed medications in a distributed data network: application of a semi-automated monitoring system. Clin Pharmacol Ther (2012) 1.20

The use of vitamin supplements and the risk of cataract among US male physicians. Am J Public Health (1994) 1.19

Temporal bone studies of the human peripheral vestibular system. Normative vestibular hair cell data. Ann Otol Rhinol Laryngol Suppl (2000) 1.18

Body mass index and the incidence of visually significant age-related maculopathy in men. Arch Ophthalmol (2001) 1.17

Trends in serum uric acid levels 1961--1980. Arthritis Rheum (1983) 1.17

Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians. Arch Ophthalmol (2001) 1.16

Social contexts and motives for drinking in men. J Stud Alcohol (1983) 1.16

Temporal bone studies of the human peripheral vestibular system. Meniere's disease. Ann Otol Rhinol Laryngol Suppl (2000) 1.13

Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism. J Gen Intern Med (2000) 1.13

Analgesic use and renal function in men. JAMA (2001) 1.13

Preservation of hearing and facial nerve function in resection of acoustic neuroma. Laryngoscope (1992) 1.12

Temporal bone studies of the human peripheral vestibular system. Normative Scarpa's ganglion cell data. Ann Otol Rhinol Laryngol Suppl (2000) 1.12

Alcohol consumption and mortality in an American male population: recovering the U-shaped curve--findings from the normative Aging Study. J Stud Alcohol (1992) 1.11

Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians. Circulation (1997) 1.11

Standardized rates of recurrent outcomes. Stat Med (1994) 1.09

Aspirin use and cognitive function in the elderly. Am J Epidemiol (1996) 1.09

Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology (1990) 1.09

Confirmation of self-reported cataract in the Physicians' Health Study. Ophthalmic Epidemiol (1994) 1.08

Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. Circulation (1997) 1.08

Moderate alcohol consumption and risk for angina pectoris or myocardial infarction in U.S. male physicians. Ann Intern Med (1997) 1.07

Variability in length of hospitalization for stroke. The role of managed care in an elderly population. Arch Neurol (1996) 1.07

Long-term efficacy of argon laser trabeculoplasty. A 10-year follow-up study. Ophthalmology (1993) 1.07

Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs. J Intern Med (2014) 1.06

Aspirin use and risk of cataract in posttrial follow-up of Physicians' Health Study I. Arch Ophthalmol (2001) 1.05

Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women. J Thromb Haemost (2009) 1.05

The relationship of the peripheral leukocyte count and cigarette smoking to pulmonary function among adult men. Chest (1984) 1.05

Changes in cholesterol and triglyceride as predictors of ischemic heart disease in men. Circulation (1982) 1.04

Change in drinking behaviors with retirement: findings from the normative aging study. J Stud Alcohol (1989) 1.03

Smoking cessation in a prospective study of healthy adult males: effects of age, time period, and amount smoked. Am J Public Health (1983) 1.02

Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann Intern Med (1997) 1.00

Patient noncompliance in the managed care setting. The case of medical therapy for glaucoma. Med Care (1998) 1.00